A 35-year-old man of Indian descent presents with progressive bone deformities, blue sclerae, and recurrent fractures since childhood. His mother and maternal grandfather had similar features. Serum alkaline phosphatase is markedly elevated. A bone biopsy shows disorganized collagen fiber architecture with poor mineralization. Genetic testing reveals a heterozygous mutation in COL1A1. Which of the following biochemical defects best explains the pathophysiology of this disorder?

Explanation

## Clinical Diagnosis: Osteogenesis Imperfecta (OI) Type I ### Clinical Presentation This patient has the classic features of **autosomal dominant OI**: - Recurrent fractures (bone fragility) - Blue sclerae (scleral thinning with visualization of underlying choroid) - Progressive bone deformities - Family history (maternal inheritance pattern) - Elevated alkaline phosphatase (increased bone turnover) ### Genetic Basis **Key Point:** OI is caused by mutations in **COL1A1 or COL1A2 genes**, which encode **Type I collagen** (the most abundant collagen in bone, skin, and tendons). **High-Yield:** Type I collagen comprises ~90% of organic bone matrix and is essential for: - Bone strength and elasticity - Scleral integrity - Skin tensile strength - Tendon and ligament structure ### Pathophysiology of OI Type I ```mermaid flowchart TD A[COL1A1/COL1A2 Mutation]:::outcome --> B[Glycine Substitution<br/>in Collagen Sequence]:::outcome B --> C[Disrupted Triple Helix Formation]:::urgent C --> D[Abnormal Collagen Fiber Architecture]:::outcome D --> E[Reduced Bone Strength]:::outcome E --> F[Recurrent Fractures]:::urgent D --> G[Scleral Thinning]:::outcome G --> H[Blue Sclerae]:::outcome D --> I[Skin Fragility]:::outcome ``` ### Why Glycine Substitution Causes OI **Mnemonic: GGG** — **G**lycine **G**aps **G**enerate **G**ross collagen defects 1. **Collagen triple helix structure**: Every 3rd amino acid in collagen is **glycine** (Gly-X-Y repeating pattern) 2. **Glycine is the smallest amino acid** — only it can fit in the interior of the tight triple helix 3. **Glycine substitution** → bulkier amino acid replaces glycine → helix destabilization 4. **Result**: Abnormal fibril assembly, poor cross-linking, and mechanical weakness ### Biochemical Defects in OI: Differential | Defect | Enzyme/Gene | OI Type | Clinical Features | |--------|------------|--------|-------------------| | **Glycine substitution** | COL1A1/COL1A2 | I, II, III, IV | Most common; variable severity | | Defective hydroxylation | Prolyl hydroxylase (Vitamin C deficiency) | N/A (Scurvy) | Gum bleeding, poor wound healing, not OI | | Impaired cross-linking | Lysyl oxidase deficiency | Menkes disease, Cutis laxa | Copper metabolism disorder, not OI | | ↓ Collagen synthesis | Transcriptional defect | Rare OI variants | Would present with low collagen, not disorganized fibrils | **Clinical Pearl:** The **disorganized collagen fiber architecture with poor mineralization** on bone biopsy is the hallmark of OI — it reflects the structural instability of the collagen triple helix due to glycine substitution, NOT a deficiency of collagen quantity. **Warning:** Do NOT confuse OI with: - **Scurvy** (Vitamin C deficiency) → defective hydroxylation of proline/lysine, but acquired, not genetic - **Menkes disease** (copper deficiency) → lysyl oxidase deficiency, X-linked, with neurological symptoms - **Cutis laxa** (lysyl oxidase deficiency) → skin laxity and emphysema, not bone fragility